Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 6/20 | 1.00 |
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 2/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | SERPINA6 | P08185 | 1/20 | 1.00 |
| ▸ | NR3C2 | P08235 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | AR | P10275 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | MGAM | O43451 | 1/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.70 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.68 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.68 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.68 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stanolone SCHEMBL619535 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL3486722 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL1502216 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL15963544 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL24684703 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL1570704 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL24410503 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL9340073 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL21442439 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR | |
| Stanolone SCHEMBL27379 | 1.00 | SHBG (1.00) | SHBGGPBAR1CYP19A1NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029741-B1 | 5 beta dihydrotestosterone pharmaceutical formulations and related methods | CORBOY JR EDWARD DUNNE (US) | 2024-07-09 | — | — | US | claimed |
| US-20220057384-A1 | SLEEP MODULATION AGENT | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-02-24 | — | — | US | claimed |
| US-20100317639-A1 | Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids | PETRONI ANNA | 2010-12-16 | — | — | US | claimed |
| EP-1962856-B1 | MEDICAMENT BASED ON A MONOESTER OF STEROIDS WITH LONG CHAIN FATTY ACIDS | PETRONI ANNA (IT) | 2010-10-20 | — | — | EP | claimed |
| EP-1807062-A4 | USE OF ANDROGENS TO REDUCE THE LIKELIHOOD OF ACQUIRING OR TO TREAT SKIN AGING | ENDORECH INC (CA) | 2009-06-03 | — | — | EP | claimed |
| EP-1807062-A1 | USE OF ANDROGENS TO REDUCE THE LIKELIHOOD OF ACQUIRING OR TO TREAT SKIN AGING | Endorecherche Inc. (CA) | 2007-07-18 | — | — | EP | claimed |
| US-20060178352-A1 | Use of androgens to reduce the likelihood of acquiring or to treat skin aging | ENDORECHERCHE, INC. | 2006-08-10 | — | — | US | claimed |
| WO-2006047859-A1 | USE OF ANDROGENS TO REDUCE THE LIKELIHOOD OF ACQUIRING OR TO TREAT SKIN AGING | ENDORECHERCHE, INC. (CA) | 2006-05-11 | — | — | WO | claimed |
| US-20040223983-A1 | Pharmaceutical preparations, use of these preparations and process for increasing the biovailability of pharmaceutical substances to be administered perorally | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-11-11 | — | — | US | claimed |
| EP-0700291-A4 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO INC (US) | 1996-07-03 | — | — | EP | claimed |
| EP-0700291-A1 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO. INC. (US) | 1996-03-13 | — | — | EP | claimed |
| US-5439900-A | Synergistic mixture of steroid and alcohol | BUKUSOGLU CUNEYT (US) | 1995-08-08 | — | — | US | claimed |
| US-4097334-A | Process for the preparation of androstane-3,17-dione derivatives | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-06-27 | — | — | US | claimed |
| US-12029741-B1 | 5 beta dihydrotestosterone pharmaceutical formulations and related methods | CORBOY JR EDWARD DUNNE (US) | 2024-07-09 | — | — | US | disclosed |
| US-12029741-B1 | 5 beta dihydrotestosterone pharmaceutical formulations and related methods | CORBOY JR EDWARD DUNNE (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240117436-A1 | METHODS OF TREATING LIPEDEMA INCLUDING AKR1C2 AS A THERAPEUTIC TARGET | MAGI EUREGIO SCS (IT) | 2024-04-11 | — | — | US | disclosed |
| US-4097334-A | Process for the preparation of androstane-3,17-dione derivatives | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-06-27 | — | — | US | disclosed |
| US-4092413-A | Antiandrogens as platelet aggregation inhibitors | MERCK & CO., INC. (US) | 1978-05-30 | — | — | US | disclosed |
| US-4013688-A | STEROIDS | THE UPJOHN COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
| US-3990956-A | Electrochemical reduction of α,β-unsaturated keto steroids | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317639-A1 | Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids | ACAT1, ACAT2, HSD17B12 | SHBG 328/4885GPBAR1 360/4885CYP19A1 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.